Article info

Download PDFPDF
Research paper
Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study

Authors

  1. Correspondence to Jette Stokholm, Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, N6702, 9 Blegdamsvej, Copenhagen 2100, Denmark; jette.stokholm{at}rh.regionh.dk
View Full Text

Citation

Stokholm J, Teasdale TW, Johannsen P, et al
Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study

Publication history

  • Received August 2, 2012
  • Revised October 11, 2012
  • Accepted October 13, 2012
  • First published November 10, 2012.
Online issue publication 
January 10, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.